# Nebulized Dexmedetomidine, Ketamine, or Midazolam in Children Undergoing Adenotonsillectomy

> **NCT07564037** · NA · COMPLETED · sponsor: **Tanta University** · enrollment: 60 (actual)

## Conditions studied

- Dexmedetomidine
- Adenotonsillectomy
- Midazolam
- Children

## Interventions

- **DRUG:** Group K:nebulized ketamine group
- **DRUG:** Group D:dexmedetomidine group
- **DRUG:** Group M: midazolam group

## Key facts

- **NCT ID:** NCT07564037
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-30
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07564037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07564037, "Nebulized Dexmedetomidine, Ketamine, or Midazolam in Children Undergoing Adenotonsillectomy". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT07564037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*